Podcasts
The MidDayBell: How NetraMark’s Explainable AI Could Transform Clinical Trials
George Achilleos, CEO of NetraMark, and Dr. Luca Pani, Chief Innovation & Regulatory Officer, discuss NetraMark’s explainable AI, model-derived subpopulations, a collaboration with NIMH, onboarding with Worldwide Clinical Trials, and an upcoming FDA Critical Path...
AI for Pharma Growth: Quantum Computation In Medicine: The Challenges, What Comes After Large Language Models For Medicine
In this episode, we explore the future of medicine beyond artificial intelligence with Dr. Joseph Geraci — mathematician, medical scientist, and quantum machine learning pioneer. While today’s AI breakthroughs and large language models (LLMs) have transformed...
Driving the Business of Science: AI in Clinical Trials. A Scientist’s Perspective.
AI in Clinical Trials. A Scientist's Perspective. In this episode of Driving the Business of Science,Keith Parent, CEO of Court Square Group, discusses the intersection of science and business in drug development with Dr. Joseph Geraci, Founder, Chief Scientific and...
Ontario Brain Institute: How AI is Transforming Depression Care with NetraMark
View the recording below to learn how NetraMark is pioneering advanced neuroscience tools and a new class of AI to revolutionize mental health care.Dr. Joseph Geraci demonstrates how NetraMark is: Applying graph theory imaging tools developed with OBI support...
AI for Pharma Growth: Modern AI Problems
The Problems that Modern AI Methods have with patient populations in oncology and neuroscience This podcast features many experts who have developed powerful AI-powered tools that are the secret behind some time-saving and supercharged revenue-generating business...